Ignite Creation Date:
2024-05-06 @ 1:45 AM
Last Modification Date:
2024-10-26 @ 11:09 AM
Study NCT ID:
NCT01896154
Status:
COMPLETED
Last Update Posted:
2016-11-17
First Post:
2013-07-02
Brief Title:
Pilot Study on Effect Size of Non-digestible Polysaccharides NPS on Immunity
Sponsor:
Clinical Research Center Kiel GmbH
Organization:
Clinical Research Center Kiel GmbH
Study Overview
Official Title:
A Randomized Controlled Clinical Study on the Effect of Non-digestible Polysaccharides NPS on the Immune Response to Influenza Vaccination in Elderly
Status:
COMPLETED
Status Verified Date:
2015-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Fib-P-2012
Brief Summary:
The aim of the study is to estimate the effect size of a 5-week consumption period of different dietary non-digestible polysaccharides NPS on antibody response to influenza vaccination and cellular immunity of healthy volunteers aged 50 for clarifying whether these NPS may enable enhancement of immune defence and to estimate the sample size for a confirmative trial Furthermore the effects on faecal microbiota and its metabolites will be investigated
Detailed Description:
The study is conducted in the frame of the collaborative project FibeBiotics Nr 289517 Fibers as support of the Gut and Immune function of Elderly - From polysaccharide compound to health claim within the Seventh Framework Programme FP7 for Research and Technological Development of the European Union EU
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None